Evanston Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-102,783
| Closed | -$6.98M | – | 69 |
|
|
2017
Q1 | $6.98M | Buy |
102,783
+24,190
| +31% | +$1.64M | 1.89% | 33 |
|
|
2016
Q4 | $5.63M | Buy |
78,593
+2,464
| +3% | +$176K | 1.73% | 35 |
|
|
2016
Q3 | $6.02M | Buy |
76,129
+7,342
| +11% | +$581K | 1.89% | 30 |
|
|
2016
Q2 | $5.74M | Buy |
68,787
+4,686
| +7% | +$391K | 1.87% | 26 |
|
|
2016
Q1 | $5.89M | Buy |
64,101
+3,230
| +5% | +$297K | 1.94% | 29 |
|
|
2015
Q4 | $6.16M | Buy |
60,871
+1,238
| +2% | +$125K | 2.15% | 23 |
|
|
2015
Q3 | $5.86M | Buy |
59,633
+1,812
| +3% | +$178K | 1.94% | 25 |
|
|
2015
Q2 | $6.77M | Buy |
57,821
+678
| +1% | +$79.4K | 2.22% | 7 |
|
|
2015
Q1 | $5.61M | Buy |
57,143
+54,928
| +2,480% | +$5.39M | 1.84% | 34 |
|
|
2014
Q4 | $209K | Hold |
2,215
| – | – | 0.07% | 61 |
|
|
2014
Q3 | $236K | Buy |
+2,215
| New | +$236K | 0.08% | 62 |
|